Search
for
Sort by
Research 961–990 of 1000+
- <i>Platycladus orientalis</i> Leaves: A Systemic Review on Botany, Phytochemistry and Pharmacology
- Farmácia Militar do Laboratório Nacional do Medicamento, Porto e Serviços Farmacêuticos do Centro Hospitalar Universitário do Porto (Hospital de Santo António), EPE, Porto
- Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naïve vaccinees
- Dermoscopy-assisted prevalence of hair loss after COVID-19 vaccination among an Egyptian population: a cross-sectional study
- Persistence of Long-COVID symptoms in a heterogenous prospective cohort
- Alopecia universalis after injection of messenger RNA COVID-19 vaccine. A case report
- Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: A multicenter study
- Fármacos de uso frecuente en dermatología como terapia para COVID-19
- Cutaneous Adverse Drug Reactions (CADRs) to COVID19 vaccines: A case series
- A Study of Cutaneous Manifestations in Patients During the Post-COVID Period in A Tertiary Care Center
- How coronavirus disease 2019 vaccination affect the level of vitamin D in serum and hair?
- Post-acute COVID-19 symptom risk in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis
- Early-onset effluvium secondary to COVID-19: Clinical and histologic characterization
- Impact of androgen deprivation therapy on mortality of prostate cancer patients with COVID-19: a propensity score-based analysis
- Association of androgenetic alopecia with a more severe form of COVID-19 infection
- Evaluating the Role of the Gabrin Sign in Predicting COVID-19 Severity Among Patients with Androgenic Alopecia
- COVID-19-associated Telogen Effluvium After Hospital Discharge: A Prospective Cohort Study.
- Telogen effluvium and COVID-19: a cross-sectional study.
- Cutaneous Manifestations of COVID-19: A Brief Review of a Possible Diagnostic Tool
- COVID-19-Related Neuropathic Pain: A Systematic Review and Meta-Analysis
- Transverse Leukonychia and Beau Lines Following COVID-19 Vaccination
- Reply to early onset effluvium secondary to COVID-19 and body-hair effluvium
- Rapidly progressive alopecia areata totalis in a COVID‐19 patient, unresponsive to tofacitinib
- APPROACHING ALOPECIA TREATMENT VIA POLYMERIC NANOPARTICLES: A BRIEF OVERVIEW
- Enanthem in Patients With COVID-19 and Skin Rash
- COVID‐19 with dermatologic manifestations and implications: An unfolding conundrum
- An update of anti-viral treatment of COVID-19
- Public interest in dermatologic symptoms, conditions, treatments, and procedures during the COVID‐19 pandemic: Insights from Google Trends
- An open-label prospective observational study of antiandrogen and non-antiandrogen early pharmacological approaches in females with mild-to-moderate COVID-19. The Pre-AndroCoV Female Trial
- Proxalutamide Improves Inflammatory, Immunologic, and Thrombogenic Markers in Mild-to-Moderate COVID-19 Males and Females: an Exploratory Analysis of a Randomized, Double-Blinded, Placebo-Controlled Trial Early Antiandrogen Therapy (EAT) with Proxalutamide (The EAT-Proxa Biochemical AndroCoV-Trial)